Delivery Order SPE2DB24D9120-SPE2DB24FVWJ6
Award Date
9/20/24
Potential Completion Date
10/11/24
Potential Value
$4.3K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $5,002.83 for the procurement of NEXPLANON 68 MG IMPLANTS. The contract is a firm fixed-price award with no set-aside designation, issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. DMS Pharmaceutical Group specializes in supplying a wide range of pharmaceutical products and medical supplies to the Department of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The $7,146.90 firm fixed-price delivery order has an ultimate completion date of September 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, provides for the delivery of NEXPLANON 68 MG IMPLANTS to the Department of Defense (DoD) and Department of Veterans Affairs (VA) medical facilities. The firm fixed-price delivery order, valued at $4,288.14, was awarded on September 25, 2024, with an ultimate completion date of October 17, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a Firm Fixed Price delivery order worth $4,288.14 awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The contract is for the delivery of NEXPLANON 68 MG IMPLANTS, a contraceptive device, with a performance period through October 21, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of pharmaceutical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $8,576.28. The contract is for the supply of NEXPLANON 68 MG IMPLANTS to the Department of Defense's Medical Supply Chain. The award does not have a set-aside designation. This contract is issued under a larger Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group Inc. holds with the Defense Logistics Agency (DLA) under the SPE2DB program. The...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is for the delivery of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The firm fixed-price delivery order, valued at $7,146.90, has an ultimate completion date of September 19, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications, including branded and generic...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $41,024.40 under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract (IDC). The IDC, which has a ceiling value of up to $499,999,999, covers a comprehensive range of pharmaceutical products to support the recurring medical supply needs of military health facilities worldwide. This specific delivery order is for NEXPLANON 68 MG IMPLANTS, with a period of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $3,471.55 for the supply of NEXPLANON 68 MG IMPLANTS to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of March 27, 2025 and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $14,293.80 for the supply of Nexplanon 68 MG implants. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 9, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, leveraging DMS Pharmaceutical Group's status as a woman-owned small business. This award is part of a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $8,331.72 firm-fixed-price delivery order is for the supply of NEXPLANON 68 MG IMPLANTS, with a completion date of June 26, 2025. DMS Pharmaceutical Group is an established federal contractor, holding a significant Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999 through November 2026. This IDC enables the DLA to issue delivery...